Exploring Cannabis and Cardiovascular Health: Join the NYCannabis Grand Rounds
The New York State Office of Cannabis Management (NYS OCM) is gearing up for a groundbreaking event in the world of medical cannabis, and this one is aimed squarely at healthcare professionals, educators, and researchers seeking to dive deeper into the therapeutic potential of cannabis. On Monday, February 24 at 4:20 PM ET, the first installment of the NYCannabis Grand Rounds series will kick off, and it's one you won’t want to miss.
In this inaugural session, the focus will be on the use of cannabis for the prevention and management of atherosclerotic cardiovascular disease (ASCVD). The medical community is increasingly recognizing the need for new approaches to cardiovascular health, and cannabis may have a role to play. Led by Dr. Maurice Hinson, this in-depth discussion promises to bring evidence-based insights into the therapeutic benefits and clinical considerations of using cannabis in managing cardiovascular disease.
A Crucial Conversation for Healthcare Providers
For anyone working in the healthcare or research fields, the NYCannabis Grand Rounds offers a rare opportunity to gain advanced knowledge and connect with experts in the field of medical cannabis. In the case of ASCVD—one of the leading causes of death in the United States—finding new methods to prevent and manage the condition is critical. With an increasing number of patients turning to alternative treatments, the role of cannabis in heart health is one that warrants serious attention.
Dr. Maurice Hinson, a well-respected voice in the medical cannabis community, will lead the session. Known for his expertise and deep understanding of both the clinical and scientific aspects of cannabis therapy, Dr. Hinson will present Clinical Considerations in the Use of Cannabis for the Prevention and Management of Atherosclerotic Cardiovascular Disease. This presentation will focus on current research, promising data, and practical considerations for integrating cannabis into cardiovascular care, especially in patients struggling with ASCVD.
The event will be moderated by Sang Choi, R.Ph., a prominent figure in cannabis education and policy, ensuring a structured and dynamic discussion. Together, Dr. Hinson and Sang Choi will break down complex medical topics and translate them into actionable insights that healthcare providers can use in their practice.
Why Now?
The timing of this discussion couldn’t be more relevant. As the medical cannabis landscape continues to evolve across the United States, so too does the understanding of its potential to address a wide array of health concerns. While cannabis has long been a subject of debate, its role in managing certain chronic diseases is becoming clearer.
Atherosclerotic cardiovascular disease, which occurs when fatty deposits (plaque) build up in the arteries, is a progressive condition that can lead to heart attacks, strokes, and other severe complications. Traditional treatments, while effective, often come with side effects or limitations. As a result, medical professionals are increasingly exploring complementary therapies, including cannabis, to offer patients a more holistic approach to managing cardiovascular health.
Dr. Hinson’s presentation will take a close look at the scientific evidence supporting the use of cannabis in cardiovascular care. From its potential to reduce inflammation and oxidative stress to its ability to improve vascular health, cannabis may offer therapeutic benefits that could complement traditional treatments. But, as with any emerging therapy, there are important considerations. Healthcare providers need to understand dosage, delivery methods, possible drug interactions, and the unique needs of individual patients.
Register and Join the Conversation
This event is an excellent opportunity for professionals in healthcare and research to learn from one of the foremost experts in medical cannabis and gain practical insights that can help inform their own clinical decisions. NYCannabis Grand Rounds is part of an ongoing effort by NYS OCM to foster informed discussions around the use of cannabis in medical practice and research, and this session promises to be an essential resource for those interested in the future of cannabis in healthcare.
If you're a healthcare provider, educator, or researcher, don’t miss out on this chance to be part of a forward-thinking conversation on the intersection of cannabis and cardiovascular health. The session will take place on Monday, February 24 at 4:20 PM ET, and registration is open now.
To register, simply follow the link and join the live discussion. You won’t want to miss this chance to gain valuable, evidence-based insights into the role of cannabis in modern healthcare practices.
We look forward to seeing you there—it's a conversation that could very well shape the future of healthcare in New York and beyond.
Register for 2/24 #NYCannabis Grand Rounds and stay informed about the latest in cannabis research.
For more information about New York State's cannabis industry, visit cannabis.ny.gov.